Hamilton Thorne (TSX:HTL) Current Accrued Expense : C$0.00 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Hamilton Thorne Current Accrued Expense?

Hamilton Thorne's Current Accrued Expense for the quarter that ended in Mar. 2024 was C$0.00 Mil.

Hamilton Thorne Current Accrued Expense Historical Data

The historical data trend for Hamilton Thorne's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamilton Thorne Current Accrued Expense Chart

Hamilton Thorne Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

Hamilton Thorne Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Hamilton Thorne Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Hamilton Thorne Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Hamilton Thorne's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hamilton Thorne (TSX:HTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hamilton Thorne Ltd (TSX:HTL) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

HTLZF:USA 0ZM:Germany

Address

100 Cummings Center, Suite 465E, Beverly, MA, USA, 01915

Website

https://www.hamiltonthorne.ltd

Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART) and developmental biology research markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.

Executives

Robert J Potter

Director

Hamilton Thorne (TSX:HTL) Headlines

No Headlines